Brokerages Set The Clorox Company (NYSE:CLX) Price Target at $159.62

The Clorox Company (NYSE:CLXGet Free Report) has earned a consensus recommendation of “Reduce” from the fourteen analysts that are presently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and one has given a buy recommendation to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $159.62.

CLX has been the subject of a number of recent research reports. DA Davidson cut their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. JPMorgan Chase & Co. raised their target price on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Barclays raised their target price on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 5th. Wells Fargo & Company raised their target price on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. Finally, Evercore ISI boosted their price objective on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th.

Check Out Our Latest Stock Report on Clorox

Hedge Funds Weigh In On Clorox

Institutional investors have recently bought and sold shares of the company. OneDigital Investment Advisors LLC acquired a new position in shares of Clorox during the third quarter worth about $207,000. CIBC Asset Management Inc grew its position in shares of Clorox by 6.7% during the third quarter. CIBC Asset Management Inc now owns 21,144 shares of the company’s stock worth $3,445,000 after buying an additional 1,332 shares in the last quarter. Natixis Advisors LLC grew its position in shares of Clorox by 8.3% during the third quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock worth $10,341,000 after buying an additional 4,839 shares in the last quarter. Claro Advisors LLC grew its position in shares of Clorox by 2.5% during the third quarter. Claro Advisors LLC now owns 6,599 shares of the company’s stock worth $1,075,000 after buying an additional 162 shares in the last quarter. Finally, Thrivent Financial for Lutherans grew its position in shares of Clorox by 2.7% during the third quarter. Thrivent Financial for Lutherans now owns 9,091 shares of the company’s stock worth $1,481,000 after buying an additional 236 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Up 0.2 %

NYSE CLX opened at $145.46 on Tuesday. The business has a fifty day moving average price of $153.10 and a 200 day moving average price of $159.87. Clorox has a one year low of $127.60 and a one year high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The company has a market cap of $17.92 billion, a P/E ratio of 39.74, a P/E/G ratio of 2.62 and a beta of 0.45.

Clorox (NYSE:CLXGet Free Report) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the firm posted $2.16 earnings per share. Research analysts anticipate that Clorox will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.35%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio is currently 133.33%.

Clorox Company Profile

(Get Free Report

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.